Drug recall · October 14, 2015
Sermorelin 6mg/6mL Lyophilized Powder recall
Why: Lack of Assurance of Sterility: A recent FDA inspection found that this product was not being compounded in an area appropriate for lyophilization which may lead to a lack of sterility assurance.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Sermorelin 6mg/6mL Lyophilized Powder, Sterile Compound for Subcutaneous Injection, Diabetes Corporation of America dba DCA Pharmacy, Franklin, TN 37064-5527
- Lots / codes
Lot #: 101614, Exp 4/30/2015
- Quantity
- 129 vials
- Company
- Diabetes Corporation of America dba DCA Pharmacy, Franklin, TN
- Distribution
- KY, OH, TN
- Initiated
- September 23, 2015 · Voluntary: Firm initiated
- Classified
- October 5, 2015
- Reported
- October 14, 2015
- Ended
- January 12, 2016
- How notified
- Telephone
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.